Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/EVT stock hub

ETR/EVT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/EVTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
920.7M
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/EVT
In the news

Latest news · ETR/EVT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 15.7P75 20.2
Trailing P/En/a
P25 16.4P50 20.9P75 30.4
ROE-24.1
P25 -6.7P50 8.5P75 17.2
ROIC-7.2
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/EVT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
198
Groups with data
11
Currency
EUR
Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Germany
Country code
DE
Employees
4,467
Employees Change
-273%
Employees Change Percent
-5.76
Enterprise value
EUR 863.4M
Exchange
Deutsche Börse Xetra
Financial currency
EUR
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
DE0005664809
Last refreshed
2026-05-10
Market cap
EUR 920.7M
Price
EUR 5.18
Price currency
EUR
Rev Per Employee
166,787.33x
Sector
Healthcare
Sic
2836
Symbol
etr/EVT
Website
https://www.evotec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-21.06%
EV Earnings
-4.45x
EV/EBITDA
31.58x
EV/FCF
-21.7x
EV/Sales
1.1x
FCF yield
-4.32%
P/B ratio
1.32x
P/S ratio
1.24x
PE Ratio10 Y
191.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-12.1%
EBITDA Margin
-2.24%
Gross margin
10.66%
Gross Profit
EUR 79.4M
Gross Profit Growth
-0.57%
Gross Profit Growth Q
70.21%
Gross Profit Growth3 Y
-13.1%
Gross Profit Growth5 Y
-1.9%
Net Income
EUR -193.9M
Net Income Growth Years
1%
Pretax Margin
-24.04%
Profit Margin
-26.02%
Profit Per Employee
EUR -43,402
ROA
-3.14
Roa5y
-0.74
ROCE
-7.41
ROE
-24.06
Roe5y
-6.22
ROIC
-7.21
Roic5y
-2.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
3.94%
Cagr15y
3.64%
Cagr1y
-26.46%
Cagr20y
1.81%
Cagr3y
-32.7%
Cagr5y
-31.26%
EPS Growth Years
1
FCF Growth Q
-17.09%
OCF Growth Q
-14.27%
Revenue Growth
-1.08x
Revenue Growth Q
14.49x
Revenue Growth Years
0x
Revenue Growth3 Y
1.61x
Revenue Growth5 Y
9.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
EUR 0.42
Assets
EUR 1.6B
Cash
EUR 444.8M
Current Assets
EUR 762.9M
Current Liabilities
EUR 368.1M
Debt
EUR 387.5M
Debt EBITDA
EUR 129
Debt Equity
EUR 0.55
Debt FCF
EUR -9.74
Equity
EUR 699.6M
Interest Coverage
-512.1
Liabilities
EUR 940.2M
Long Term Assets
EUR 876.9M
Long Term Liabilities
EUR 572.1M
Net Cash
EUR 57.3M
Net Cash By Market Cap
EUR 6.22
Net Debt Equity
EUR -0.08
Tangible Book Value
EUR 394.2M
Tangible Book Value Per Share
EUR 2.22
WACC
8.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.68
Inventory Turnover
20.02
Net Working Capital
EUR -68.2M
Quick ratio
1.45
Working Capital
EUR 287.9M
Working Capital Turnover
EUR 2.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
47.12%
1Y total return
-26.44%
200-day SMA
5.83
3Y total return
-69.52%
50-day SMA
4.97
50-day SMA vs 200-day SMA
50under200
5Y total return
-84.65%
All Time High
102
All Time High Change
-94.92%
All Time High Date
2000-03-01
All Time Low
0.54
All Time Low Change
859.26%
All Time Low Date
2009-03-03
ATR
0.28
Beta
1.3
Beta1y
1.8
Beta2y
1.18
Ch YTD
-4.95
High
5.39
High52
8.57
High52 Date
2025-05-27
High52ch
-39.53%
Low
5.13
Low52
4
Low52 Date
2026-03-13
Low52ch
29.66%
Ma50ch
4.33%
Price vs 200-day SMA
-11.18%
RSI
50.13
RSI Monthly
38.03
RSI Weekly
45.43
Sharpe ratio
-0.48x
Sortino ratio
-0.55
Total Return
-0.16%
Tr YTD
-4.95
Tr15y
71.01%
Tr1m
15.88%
Tr1w
-3.09%
Tr3m
-15.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
EUR -90.1M
Operating Income Growth Q
185.5
Operating margin
-12.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
133,553,222%
Net Borrowing
-29,418,000
Shares Institutions
35.55%
Shares Out
177,749,400
Shares Qo Q
-0.09%
Shares Yo Y
0.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
EUR -43.6M
Average Volume
849,772.3x
Bv Per Share
3.94
CAPEX
EUR -58.5M
Ch10y
47.12
Ch15y
71.01
Ch1m
15.88
Ch1w
-3.09
Ch1y
-26.44
Ch20y
43.09
Ch3m
-15.74
Ch3y
-69.52
Ch5y
-84.65
Ch6m
-1.07
Change
-1.61%
Change From Open
-3.18
Close
5.27
Days Gap
1.52
Depreciation Amortization
74,771,000
Dollar Volume
2,717,712.9
Earnings Date
2026-08-13
EBIT
EUR -90.1M
EBITDA
EUR -16.7M
EPS
EUR -1.09
F Score
4
FCF
EUR -39.8M
FCF EV Yield
-4.61x
FCF Per Share
EUR -0.22
Financing CF
-92,149,000
Fiscal Year End
December
Founded
1,993
Goodwill
272,365,000
Income Tax
EUR 14.8M
Investing CF
180,764,000
Is Primary Listing
1
Last Earnings Date
2026-04-08
Last Report Date
2025-12-31
Last Split Date
2000-08-18
Last Split Type
Forward
Ma150
5.67
Ma150ch
-8.64%
Ma20
5.31
Ma20ch
-2.5%
Net CF
102,535,000
Next Earnings Date
2026-08-13
Open
5.35
P OCF Ratio
49.2
Position In Range
19.23
Ppne
554,626,000
Price Date
2026-05-08
Ptbv Ratio
2.34
Relative Volume
0.62x
Revenue
745,039,000x
SBC By Revenue
0.51x
Share Based Comp
3,778,000
Tax By Revenue
1.98x
Tr20y
43.09%
Tr6m
-1.07%
Volume
524,655
Z Score
0.42
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ETR/EVT pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/EVT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.4%
S&P 500 1Y: n/a
3Y total return
-69.5%
S&P 500 3Y: n/a
5Y total return
-84.6%
S&P 500 5Y: n/a
10Y total return
+47.1%
S&P 500 10Y: n/a
Ownership

Who owns ETR/EVT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+35.5%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.2%
Negative means the company is buying back shares.
Technical

ETR/EVT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
50.1
Neutral momentum band
Price vs 200-day MA
-11.2%
50/200-day relationship not available
Beta (5Y)
1.30
More volatile than the market
Sharpe ratio
-0.48
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/EVT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/EVT stock rating?

etr/EVT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/EVT analysis?

The full report lives at /stocks/etr/EVT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/EVT?

The latest report frames etr/EVT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/EVT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.